OTC Healthcare in Egypt to 2013

Introduction

This databook provides key data and information on the OTC healthcare market in Egypt. This report is a comprehensive resource for market, category and segment level data including value, distribution share and company & brand share.

Scope

*Contains information on:analgesics,medicated skin product,topical OTC,traditional,indigestion,cough&cold,plasters&Bandages,vitamins and first aid kits

*Market,category and segment level information on value with historic (2003-2008) and forecast (2009-2013) data

*Category level company and brand share as well as distribution share information for 2007 and 2008

*Review of the top two companies within the OTC healthcare market, including company overview, key facts and business description

Highlights

The market for OTC healthcare in Egypt increased at a compound annual growth rate of 8.8% between 2003 and 2008.

The analgesics category led the OTC healthcare market in Egypt, accounting for a share of 23.1%.

Leading players in Egyptian OTC healthcare market include GlaxoSmithKline Plc, Johnson & Johnson and Amoun Pharmaceuticals Co.

Reasons to Purchase

*Develop business strategies by understanding the quantitative trends within the OTC healthcare market in Egypt

*Design effective marketing and sales strategies by identifying key market categories and segments

*Identify key players within the market to plan lucrative M&A, partnerships and agreements


Report Highlights

[Studien Infos ausblenden]

TABLE OF CONTENTS
Chapter 1 Executive Summary 2
Summary market level: OTC healthcare 2
Summary category level: analgesics 3
Summary category level: topical OTC medicines 4
Summary category level: cough and cold preparations 5
Summary category level: indigestion preparations 6
Summary category level: medicated skin products 7
Summary category level: first aid kits 8
Summary category level: other OTC healthcare products 9
Summary category level: plasters & bandages 10
Summary category level: traditional medicines 11
Summary category level: vitamins and minerals 12
Chapter 2 Introduction 13
What is this report about? 13
How to use this report 13
Market definition 14
Chapter 3 Market Overview 30
Value analysis (Egyptian Pound), 2003?08 30
Value analysis (Egyptian Pound), 2008?13 32
Value analysis (US dollars), 2003?08 34
Value analysis (US dollars), 2008?13 35
Company and brand share analysis 37
Distribution analysis 44
Chapter 4 Leading Company Profiles 46
GlaxoSmithKline Plc 46
Johnson & Johnson 49
Chapter 5 Category Analysis: Analgesics 51
Value analysis (Egyptian Pound), 2003?08 51
Value analysis (Egyptian Pound), 2008?13 52
Value analysis (US dollars), 2003?08 54
Value analysis (US dollars), 2008?13 55
Company and brand share analysis 57
Distribution analysis 60
Chapter 6 Category Analysis: Topical OTC Medicines 62
Value analysis (Egyptian Pound), 2003?08 62
Value analysis (Egyptian Pound), 2008?13 63
Value analysis (US dollars), 2003?08 65
Value analysis (US dollars), 2008?13 66
Company and brand share analysis 68
Distribution analysis 71
Chapter 7 Category Analysis: Cough and Cold Preparations 73
Value analysis (Egyptian Pound), 2003?08 73
Value analysis (Egyptian Pound), 2008?13 74
Value analysis (US dollars), 2003?08 76
Value analysis (US dollars), 2008?13 77
Company and brand share analysis 79
Distribution analysis 82
Chapter 8 Category Analysis: Indigestion Preparations 84
Value analysis (Egyptian Pound), 2003?08 84
Value analysis (Egyptian Pound), 2008?13 85
Value analysis (US dollars), 2003?08 87
Value analysis (US dollars), 2008?13 87
Company and brand share analysis 89
Distribution analysis 92
Chapter 9 Category Analysis: Medicated Skin Products 94
Value analysis (Egyptian Pound), 2003?08 94
Value analysis (Egyptian Pound), 2008?13 95
Value analysis (US dollars), 2003?08 97
Value analysis (US dollars), 2008?13 98
Company and brand share analysis 100
Distribution analysis 103
Chapter 10 Category Analysis: First Aid Kits 105
Value analysis (Egyptian Pound), 2003?08 105
Value analysis (Egyptian Pound), 2008?13 106
Value analysis (US dollars), 2003?08 107
Value analysis (US dollars), 2008?13 107
Company and brand share analysis 108
Distribution analysis 111
Chapter 11 Category Analysis: Other OTC Healthcare Products 113
Value analysis (Egyptian Pound), 2003?08 113
Value analysis (Egyptian Pound), 2008?13 114
Value analysis (US dollars), 2003?08 116
Value analysis (US dollars), 2008?13 117
Company and brand share analysis 119
Distribution analysis 122
Chapter 12 Category Analysis: Plasters & Bandages 124
Value analysis (Egyptian Pound), 2003?08 124
Value analysis (Egyptian Pound), 2008?13 125
Value analysis (US dollars), 2003?08 127
Value analysis (US dollars), 2008?13 128
Company and brand share analysis 130
Distribution analysis 133
Chapter 13 Category Analysis: Traditional Medicines 135
Value analysis (Egyptian Pound), 2003?08 135
Value analysis (Egyptian Pound), 2008?13 136
Value analysis (US dollars), 2003?08 137
Value analysis (US dollars), 2008?13 137
Company and brand share analysis 138
Distribution analysis 141
Chapter 14 Category Analysis: Vitamins and Minerals 143
Value analysis (Egyptian Pound), 2003?08 143
Value analysis (Egyptian Pound), 2008?13 144
Value analysis (US dollars), 2003?08 146
Value analysis (US dollars), 2008?13 146
Company and brand share analysis 148
Distribution analysis 151
Chapter 15 Country Comparison 153
Value 153
Market share 157
Chapter 16 PESTLE Analysis 158
Summary 158
Political analysis 159
Economic analysis 162
Social analysis 165
Technological analysis 168
Legal analysis 172
Environmental analysis 175
Chapter 17 New Product Development 177
Product launches over time 177
Recent product launches 179
Chapter 18 Macroeconomic Profile 180
Macroeconomic indicators 180
Chapter 19 Research Methodology 185
Methodology overview 185
Secondary research 186
Market modeling 187
Creating an initial data model 187
Revising the initial data model 187
Creating a final estimate 188
Creating demographic value splits 188
Primary research 188
Data finalization 189
Ongoing research 189
Chapter 20 APPENDIX 190
Future readings 190
How to contact experts in your industry 190
Disclaimer 190

LIST OF FIGURES
Figure 1: Egypt OTC healthcare value and value forecast, 2003?13 (EGPm, nominal prices) 33
Figure 2: Egypt OTC healthcare category growth comparison, by value, 2003?13 36
Figure 3: Egypt OTC healthcare company share, by value, 2007?08 (%) 41
Figure 4: Egypt OTC healthcare distribution channels, by value, 2007?08 (%) 45
Figure 5: Egypt analgesics value and value forecast, 2003?13 (EGPm, nominal prices) 53
Figure 6: Egypt analgesics category growth comparison, by value, 2003?13 56
Figure 7: Egypt analgesics company share, by value, 2007?08 (%) 58
Figure 8: Egypt analgesics distribution channels, by value, 2007?08 (%) 61
Figure 9: Egypt topical OTC medicines value and value forecast, 2003?13 (EGPm, nominal prices) 64
Figure 10: Egypt topical OTC medicines category growth comparison, by value, 2003?13 67
Figure 11: Egypt topical OTC medicines company share, by value, 2007?08 (%) 69
Figure 12: Egypt topical OTC medicines distribution channels, by value, 2007?08 (%) 72
Figure 13: Egypt cough and cold preparations value and value forecast, 2003?13 (EGPm, nominal prices) 75
Figure 14: Egypt cough and cold preparations category growth comparison, by value, 2003?13 78
Figure 15: Egypt cough and cold preparations company share, by value, 2007?08 (%) 80
Figure 16: Egypt cough and cold preparations distribution channels, by value, 2007?08 (%) 83
Figure 17: Egypt indigestion preparations value and value forecast, 2003?13 (EGPm, nominal prices) 86
Figure 18: Egypt indigestion preparations category growth comparison, by value, 2003?13 88
Figure 19: Egypt indigestion preparations company share, by value, 2007?08 (%) 90
Figure 20: Egypt indigestion preparations distribution channels, by value, 2007?08 (%) 93
Figure 21: Egypt medicated skin products value and value forecast, 2003?13 (EGPm, nominal prices) 96
Figure 22: Egypt medicated skin products category growth comparison, by value, 2003?13 99
Figure 23: Egypt medicated skin products company share, by value, 2007?08 (%) 101
Figure 24: Egypt medicated skin products distribution channels, by value, 2007?08 (%) 104
Figure 25: Egypt first aid kits value and value forecast, 2003?13 (EGPm, nominal prices) 106
Figure 26: Egypt first aid kits company share, by value, 2007?08 (%) 109
Figure 27: Egypt first aid kits distribution channels, by value, 2007?08 (%) 112
Figure 28: Egypt other OTC healthcare products value and value forecast, 2003?13 (EGPm, nominal prices) 115
Figure 29: Egypt other OTC healthcare products category growth comparison, by value, 2003?13 118
Figure 30: Egypt other OTC healthcare products company share, by value, 2007?08 (%) 120
Figure 31: Egypt other OTC healthcare products distribution channels, by value, 2007?08 (%) 123
Figure 32: Egypt plasters & bandages value and value forecast, 2003?13 (EGPm, nominal prices) 126
Figure 33: Egypt plasters & bandages category growth comparison, by value, 2003?13 129
Figure 34: Egypt plasters & bandages company share, by value, 2007?08 (%) 131
Figure 35: Egypt plasters & bandages distribution channels, by value, 2007?08 (%) 134
Figure 36: Egypt traditional medicines value and value forecast, 2003?13 (EGPm, nominal prices) 136
Figure 37: Egypt traditional medicines company share, by value, 2007?08 (%) 139
Figure 38: Egypt traditional medicines distribution channels, by value, 2007?08 (%) 142
Figure 39: Egypt vitamins and minerals value and value forecast, 2003?13 (EGPm, nominal prices) 145
Figure 40: Egypt vitamins and minerals category growth comparison, by value, 2003?13 147
Figure 41: Egypt vitamins and minerals company share, by value, 2007?08 (%) 149
Figure 42: Egypt vitamins and minerals distribution channels, by value, 2007?08 (%) 152
Figure 43: Global OTC healthcare market split (value terms, 2008), top five countries 154
Figure 44: Global OTC healthcare market value, 2003–08, top five countries 156
Figure 45: Annual data review process 186

LIST OF TABLES
Table 1: OTC healthcare category definitions 15
Table 2: OTC healthcare distribution channels 17
Table 3: Egypt OTC healthcare value, 2003?08 (EGPm, nominal prices) 31
Table 4: Egypt OTC healthcare value forecast, 2008?13 (EGPm, nominal prices) 32
Table 5: Egypt OTC healthcare value, 2003?08 ($m, nominal prices) 34
Table 6: Egypt OTC healthcare value forecast, 2008?13 ($m, nominal prices) 35
Table 7: Egypt OTC healthcare brand share, by value, 2007?08 (%) 37
Table 8: Egypt OTC healthcare value, by brand 2007?08 (EGPm, nominal prices) 39
Table 9: Egypt OTC healthcare company share by value, 2007?08 (%) 42
Table 10: Egypt OTC healthcare value, by company, 2007?08 (EGPm, nominal prices) 43
Table 11: Egypt OTC healthcare distribution channels, by value, 2007?08 (%) 44
Table 12: Egypt OTC healthcare value, by distribution channel, 2007?08 (EGPm, nominal prices) 44
Table 13: GlaxoSmithKline Plc key facts 46
Table 14: Johnson & Johnson key facts 49
Table 15: Egypt analgesics value, 2003?08 (EGPm, nominal prices) 51
Table 16: Egypt analgesics value forecast, 2008?13 (EGPm, nominal prices) 52
Table 17: Egypt analgesics value, 2003?08 ($m, nominal prices) 54
Table 18: Egypt analgesics value forecast, 2008?13 ($m, nominal prices) 55
Table 19: Egypt analgesics brand share, by value, 2007?08 (%) 57
Table 20: Egypt analgesics value, by brand 2007?08 (EGPm, nominal prices) 57
Table 21: Egypt analgesics company share by value, 2007?08 (%) 59
Table 22: Egypt analgesics value, by company, 2007?08 (EGPm, nominal prices) 59
Table 23: Egypt analgesics distribution channels, by value, 2007?08 (%) 60
Table 24: Egypt analgesics value, by distribution channel, 2007?08 (EGPm, nominal prices) 60
Table 25: Egypt topical OTC medicines value, 2003?08 (EGPm, nominal prices) 62
Table 26: Egypt topical OTC medicines value forecast, 2008?13 (EGPm, nominal prices) 63
Table 27: Egypt topical OTC medicines value, 2003?08 ($m, nominal prices) 65
Table 28: Egypt topical OTC medicines value forecast, 2008?13 ($m, nominal prices) 66
Table 29: Egypt topical OTC medicines brand share, by value, 2007?08 (%) 68
Table 30: Egypt topical OTC medicines value, by brand 2007?08 (EGPm, nominal prices) 68
Table 31: Egypt topical OTC medicines company share by value, 2007?08 (%) 70
Table 32: Egypt topical OTC medicines value, by company, 2007?08 (EGPm, nominal prices) 70
Table 33: Egypt topical OTC medicines distribution channels, by value, 2007?08 (%) 71
Table 34: Egypt topical OTC medicines value, by distribution channel, 2007?08 (EGPm, nominal prices) 71
Table 35: Egypt cough and cold preparations value, 2003?08 (EGPm, nominal prices) 73
Table 36: Egypt cough and cold preparations value forecast, 2008?13 (EGPm, nominal prices) 74
Table 37: Egypt cough and cold preparations value, 2003?08 ($m, nominal prices) 76
Table 38: Egypt cough and cold preparations value forecast, 2008?13 ($m, nominal prices) 77
Table 39: Egypt cough and cold preparations brand share, by value, 2007?08 (%) 79
Table 40: Egypt cough and cold preparations value, by brand 2007?08 (EGPm, nominal prices) 79
Table 41: Egypt cough and cold preparations company share by value, 2007?08 (%) 81
Table 42: Egypt cough and cold preparations value, by company, 2007?08 (EGPm, nominal prices) 81
Table 43: Egypt cough and cold preparations distribution channels, by value, 2007?08 (%) 82
Table 44: Egypt cough and cold preparations value, by distribution channel, 2007?08 (EGPm, nominal prices) 82
Table 45: Egypt indigestion preparations value, 2003?08 (EGPm, nominal prices) 84
Table 46: Egypt indigestion preparations value forecast, 2008?13 (EGPm, nominal prices) 85
Table 47: Egypt indigestion preparations value, 2003?08 ($m, nominal prices) 87
Table 48: Egypt indigestion preparations value forecast, 2008?13 ($m, nominal prices) 87
Table 49: Egypt indigestion preparations brand share, by value, 2007?08 (%) 89
Table 50: Egypt indigestion preparations value, by brand 2007?08 (EGPm, nominal prices) 89
Table 51: Egypt indigestion preparations company share by value, 2007?08 (%) 91
Table 52: Egypt indigestion preparations value, by company, 2007?08 (EGPm, nominal prices) 91
Table 53: Egypt indigestion preparations distribution channels, by value, 2007?08 (%) 92
Table 54: Egypt indigestion preparations value, by distribution channel, 2007?08 (EGPm, nominal prices) 92
Table 55: Egypt medicated skin products value, 2003?08 (EGPm, nominal prices) 94
Table 56: Egypt medicated skin products value forecast, 2008?13 (EGPm, nominal prices) 95
Table 57: Egypt medicated skin products value, 2003?08 ($m, nominal prices) 97
Table 58: Egypt medicated skin products value forecast, 2008?13 ($m, nominal prices) 98
Table 59: Egypt medicated skin products brand share, by value, 2007?08 (%) 100
Table 60: Egypt medicated skin products value, by brand 2007?08 (EGPm, nominal prices) 100
Table 61: Egypt medicated skin products company share by value, 2007?08 (%) 102
Table 62: Egypt medicated skin products value, by company, 2007?08 (EGPm, nominal prices) 102
Table 63: Egypt medicated skin products distribution channels, by value, 2007?08 (%) 103
Table 64: Egypt medicated skin products value, by distribution channel, 2007?08 (EGPm, nominal prices) 103
Table 65: Egypt first aid kits value, 2003?08 (EGPm, nominal prices) 105
Table 66: Egypt first aid kits value forecast, 2008?13 (EGPm, nominal prices) 106
Table 67: Egypt first aid kits value, 2003?08 ($m, nominal prices) 107
Table 68: Egypt first aid kits value forecast, 2008?13 ($m, nominal prices) 107
Table 69: Egypt first aid kits brand share, by value, 2007?08 (%) 108
Table 70: Egypt first aid kits value, by brand 2007?08 (EGPm, nominal prices) 108
Table 71: Egypt first aid kits company share by value, 2007?08 (%) 110
Table 72: Egypt first aid kits value, by company, 2007?08 (EGPm, nominal prices) 110
Table 73: Egypt first aid kits distribution channels, by value, 2007?08 (%) 111
Table 74: Egypt first aid kits value, by distribution channel, 2007?08 (EGPm, nominal prices) 111
Table 75: Egypt other OTC healthcare products value, 2003?08 (EGPm, nominal prices) 113
Table 76: Egypt other OTC healthcare products value forecast, 2008?13 (EGPm, nominal prices) 114
Table 77: Egypt other OTC healthcare products value, 2003?08 ($m, nominal prices) 116
Table 78: Egypt other OTC healthcare products value forecast, 2008?13 ($m, nominal prices) 117
Table 79: Egypt other OTC healthcare products brand share, by value, 2007?08 (%) 119
Table 80: Egypt other OTC healthcare products value, by brand 2007?08 (EGPm, nominal prices) 119
Table 81: Egypt other OTC healthcare products company share by value, 2007?08 (%) 121
Table 82: Egypt other OTC healthcare products value, by company, 2007?08 (EGPm, nominal prices) 121
Table 83: Egypt other OTC healthcare products distribution channels, by value, 2007?08 (%) 122
Table 84: Egypt other OTC healthcare products value, by distribution channel, 2007?08 (EGPm, nominal prices) 122
Table 85: Egypt plasters & bandages value, 2003?08 (EGPm, nominal prices) 124
Table 86: Egypt plasters & bandages value forecast, 2008?13 (EGPm, nominal prices) 125
Table 87: Egypt plasters & bandages value, 2003?08 ($m, nominal prices) 127
Table 88: Egypt plasters & bandages value forecast, 2008?13 ($m, nominal prices) 128
Table 89: Egypt plasters & bandages brand share, by value, 2007?08 (%) 130
Table 90: Egypt plasters & bandages value, by brand 2007?08 (EGPm, nominal prices) 130
Table 91: Egypt plasters & bandages company share by value, 2007?08 (%) 132
Table 92: Egypt plasters & bandages value, by company, 2007?08 (EGPm, nominal prices) 132
Table 93: Egypt plasters & bandages distribution channels, by value, 2007?08 (%) 133
Table 94: Egypt plasters & bandages value, by distribution channel, 2007?08 (EGPm, nominal prices) 133
Table 95: Egypt traditional medicines value, 2003?08 (EGPm, nominal prices) 135
Table 96: Egypt traditional medicines value forecast, 2008?13 (EGPm, nominal prices) 136
Table 97: Egypt traditional medicines value, 2003?08 ($m, nominal prices) 137
Table 98: Egypt traditional medicines value forecast, 2008?13 ($m, nominal prices) 137
Table 99: Egypt traditional medicines brand share, by value, 2007?08 (%) 138
Table 100: Egypt traditional medicines value, by brand 2007?08 (EGPm, nominal prices) 138
Table 101: Egypt traditional medicines company share by value, 2007?08 (%) 140
Table 102: Egypt traditional medicines value, by company, 2007?08 (EGPm, nominal prices) 140
Table 103: Egypt traditional medicines distribution channels, by value, 2007?08 (%) 141
Table 104: Egypt traditional medicines value, by distribution channel, 2007?08 (EGPm, nominal prices) 141
Table 105: Egypt vitamins and minerals value, 2003?08 (EGPm, nominal prices) 143
Table 106: Egypt vitamins and minerals value forecast, 2008?13 (EGPm, nominal prices) 144
Table 107: Egypt vitamins and minerals value, 2003?08 ($m, nominal prices) 146
Table 108: Egypt vitamins and minerals value forecast, 2008?13 ($m, nominal prices) 146
Table 109: Egypt vitamins and minerals brand share, by value, 2007?08 (%) 148
Table 110: Egypt vitamins and minerals value, by brand 2007?08 (EGPm, nominal prices) 148
Table 111: Egypt vitamins and minerals company share by value, 2007?08 (%) 150
Table 112: Egypt vitamins and minerals value, by company, 2007?08 (EGPm, nominal prices) 150
Table 113: Egypt vitamins and minerals distribution channels, by value, 2007?08 (%) 151
Table 114: Egypt vitamins and minerals value, by distribution channel, 2007?08 (EGPm, nominal prices) 151
Table 115: Global OTC healthcare market value, 2008 153
Table 116: Global OTC healthcare market split (value terms ($m), 2008), top five countries 156
Table 117: Leading players, top five countries 157
Table 118: Analysis of Egypt’s political landscape 159
Table 119: Analysis of Egypt’s economy 162
Table 120: Analysis of Egypt’s social system 165
Table 121: Analysis of Egypt’s technology landscape 168
Table 122: Analysis of Egypt’s legal landscape 172
Table 123: Analysis of Egypt’s environmental landscape 175
Table 124: Egypt OTC healthcare new product launches reports, by company, 2008 177
Table 125: Egypt OTC healthcare new product launches SKUs, by company, 2008 177
Table 126: Egypt OTC healthcare new product launches (reports), by flavor and fragrances, 2008 178
Table 127: Egypt OTC healthcare new product launches (reports), by ingredients, 2008 178
Table 128: Egypt OTC healthcare new product launches (reports), by package tags or claims, 2008 178
Table 129: Egypt OTC healthcare new product launches, 2008 179
Table 130: Egypt population, by age group, 2003?08 (millions) 180
Table 131: Egypt population forecast, by age group, 2008?13 (millions) 181
Table 132: Egypt population, by gender, 2003?08 (millions) 181
Table 133: Egypt population forecast, by gender, 2008?13 (millions) 182
Table 134: Egypt nominal GDP, 2003?08 (EGPbn, nominal prices) 182
Table 135: Egypt nominal GDP forecast, 2008?13 (EGPbn, nominal prices) 182
Table 136: Egypt real GDP, 2003?08 (EGPbn, 2000 prices) 183
Table 137: Egypt real GDP forecast, 2008?13 (EGPbn, 2000 prices) 183
Table 138: Egypt real GDP, 2003?08 ($bn, 2000 prices) 183
Table 139: Egypt real GDP forecast, 2008?13 ($bn, 2000 prices) 184
Table 140: Egypt consumer price index, 2003?08 (2000=100) 184
Table 141: Egypt consumer price index, 2008?13 (2000=100) 184



[Inhaltsverzeichnis ausblenden]